Crossmark

ΔBSIJ: a quantitative marker for early detection of medication-related osteonecrosis of the jaw in patients with prostate cancer receiving bone-modifying agents

Crossref DOI link: https://doi.org/10.1007/s12149-025-02078-9

Published Online: 2025-07-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kokubun, Hidetoshi

Kijima, Toshiki https://orcid.org/0000-0002-4380-9294
Tokura, Yuumi

Uematsu, Toshitaka

Takei, Kohei

Betsunoh, Hironori

Yashi, Masahiro

Nakagami, Yoshihiro

Soga, Shigeyoshi

Kamai, Takao
License Information

Text and Data Mining valid from 2025-07-03

Version of Record valid from 2025-07-03
More Information

Article History

Received: 9 January 2025

Accepted: 23 June 2025

First Online: 3 July 2025

Declarations

:

: No potential conflicts of interest were disclosed.

: Not Applicable.

Document is current

Any future updates will be listed below